The importance of the SorLA or LR11 receptor in braking Alzheimer’s was originally defined here at Emory by Jim Lah and Allan Levey’s labs. Japanese researchers recently determined the structure of SorLA and published the results in Nature Structural and Molecular Biology. Their findings point toward a direct role for SorLA in binding toxic circulating beta-amyloid and transporting it to the lysosome for degradation. Hat tip to Alzforum.
- Updates by Email
- Another side to cancer immunotherapy? Emory scientists investigate intratumoral B cells
- Don’t go slippery on me, tRNA
- Two birds with one stone: amygdala ablation for PTSD and epilepsy
- Seeing the value: prostate cancer imaging agent developed at Winship
- Unusual partnership may drive neurodegeneration in Alzheimer’s